ABT-199 (venetoclax) and BCL-2 inhibitors in clinical development
ABT-199 (venetoclax) and BCL-2 inhibitors in clinical development is a paper indexed in ScholarIQ from OpenAlex.
How many citations does ABT-199 (venetoclax) and BCL-2 inhibitors in clinical development have?
ABT-199 (venetoclax) and BCL-2 inhibitors in clinical development has 284 citations in the OpenAlex counts ScholarIQ stores.
When was ABT-199 (venetoclax) and BCL-2 inhibitors in clinical development published?
ABT-199 (venetoclax) and BCL-2 inhibitors in clinical development has 2015 year in the ScholarIQ index.
What is the open-access status of ABT-199 (venetoclax) and BCL-2 inhibitors in clinical development?
ABT-199 (venetoclax) and BCL-2 inhibitors in clinical development has gold oa status in the ScholarIQ index.
What is the DOI of ABT-199 (venetoclax) and BCL-2 inhibitors in clinical development?
The DOI for ABT-199 (venetoclax) and BCL-2 inhibitors in clinical development is on the source record.
What is the PMID of ABT-199 (venetoclax) and BCL-2 inhibitors in clinical development?
The PMID for ABT-199 (venetoclax) and BCL-2 inhibitors in clinical development is on the source record.
What is the OpenAlex record for ABT-199 (venetoclax) and BCL-2 inhibitors in clinical development?
The OpenAlex for ABT-199 (venetoclax) and BCL-2 inhibitors in clinical development is on the source record.